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Note: 
 
This project has been developed in the context of a 5-month signal processing (MATLAB) internship at 
Laboratoire de Traitement du Signal et Image (LTSI) in Rennes, France. The developed work is part of 
a research which it is still being conducted and is also part of a PhD thesis which has not been published 
yet. The followed methodology and procedures can be divulged, nevertheless, the implemented codes 
are confidential and, they are now, of LTSI’s property. This is the reason why no algorithms can be 
found nor along the project nor in the Annex chapter.  
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Resum 
El síndrome d’apnea-hipopnea durant el son (SAS) és una malaltia subdiagnosticada que afecta el 5% 
de la població general. Es caracteritza per ser una malaltia multifactorial caracteritzada per provocar 
episodis recurrents de pausa de l’acció respiratòria (apnea) o una disminució significativa de l’amplitut 
respiratòria (hypopnea) durant el son, amb la possibilitat de causar la seva fragmentació, provocant 
alteracions càrdio-respiratòries agudes associades amb el desenvolupament de la hipertensió i malaltíes 
cardiovasculars a llarg termini. En estudis anteriors, es va proposar un nou sistema de monitorització i 
teràpia del SAS, basat en l’estimulació kinestética adaptativa i no invasiva. En el present estudi, es 
presenten els resultats preliminars focalitzats en la resposta fisiològica dels pacients en termes de 
l’amplitud de la fotopletismografia de pols (PPG) i temps de trànsit del pols (PTT). 
S'ha proposat una cadena de processat de senyals que ha permès caracteritzar la fotopletismografia de 
pols per tal d'estimar la resposta autonòmica dels esdeveniments respiratoris quan la teràpia està activa 
o no.  
Tot i haver obtingut resultats benèfics pel 20% dels pacients tractats, aquests no ens permeten determinar 
de manera global l’efecte potencial de la teràpia en termes de control de la vasoconstricció perifèrica. 
Nous estudis estan actualment en curs per analitzar altres indicadors autonòmics en aquesta població. 
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Resumen 
El síndrome de apnea-hipopnea durante el sueño (SAS) es una enfermedad subdiagnosticada que afecta 
el 5% de la población general. Se caracteriza por ser una enfermedad multifactorial que causa episodios 
recurrentes de pausa de la acción respiratoria (apnea) o una reducción significativa de la amplitud 
respiratoria durante el sueño, causando así su fragmentación y provocando alteraciones cardio-
respiratorias agudas asociadas con el desarrollo de hipertensión y enfermedades cardiovasculares a largo 
plazo. En estudios anteriores, se propuso un nuevo sistema de monitorización y terapia para el SAS 
basado en la estimulación kinestésica adaptativa y no invasiva. En este estudio se presentan resultados 
preliminares complementarios focalizados en la respuesta fisiológica de los pacientes a la terapia en 
términos de amplitud de la fotopletismografía de pulso (PPG) y del tiempo de tránsito del pulso (PTT). 
Se ha propuesto una cadena de procesamiento de señales que ha permitido caracterizar la 
fotopletismografía de pulso afín de estimar una respuesta autonómica a los eventos respiratorios cuando 
la terapia esta activa o no. 
Aunque se hayan obtenido resultados benéficos para el 20% de los pacientes tratados, estos resultados 
preliminares no nos permiten determinar de forma global el efecto potencial de la terapia en términos de 
control de la vasoconstricción periférica. Nuevos estudios están actualmente en curso para analizar otros 
indicadores autonómicos en esta población. 
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Abstract 
Sleep apnea syndrome (SAS) is an underdiagnosed disease affecting up to 5% of the general population. 
It is a multifactorial disease characterized by repeated episodes of breathing pauses (apnea) or significant 
reduction in respiratory amplitude (hypopnea) during the patient sleep. that may cause sleep 
fragmentation along with acute cardio-respiratory alterations associated with the development of 
hypertension and cardiovascular diseases in the long-term. In previous works, it has been proposed a 
novel monitoring and therapeutic system for SAS, based on non-invasive adaptive kinaesthetic. This 
study presents preliminary results of the patient’s physiological response in terms of pulse 
photoplethysmography (PPG) amplitude and pulse transit time (PTT).   
It has been proposed a chain of signal processing that has allowed to characterize the pulse 
photoplethysmography in order to estimate an autonomic response to respiratory events when the 
therapy is active or not. 
Although beneficial results have been observed on 20% of treated patients, these preliminary results do 
not allow us to determine in a global way the potential effect of the therapy in terms of peripheral 
vasoconstriction control. New studies are currently under way to analyse other autonomic indicators in 
this population. 
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1. Introduction 
The sleep apnea syndrome (SAS) has a prevalence in middle age of 2% in women and 4% in men [1]. 
This condition is a multifactorial disease characterized by repeated episodes of breathing pauses (apnea) 
or significant reduction in respiratory amplitude (hypopnea) during the patient sleep. Sleep apnea is 
caused by airway occlusion or lack of diaphragmatic activation by autonomic nervous system causing 
transient asphyxia, which is reversed when the patient wakes. These events are repetitive with severely 
affected patients having hundreds of respiratory events and arousals every night [2]. In-between its main 
clinical features we can find disordered respiration during sleep, daytime sleepiness, impaired daytime 
cognitive performance, reduced quality of life, increased risk of road traffic accident due to excessive 
sleepiness and dysphoric mood. It has been observed that patients have increased mortality and 
morbidity from cardiovascular events [3] due to the raise of blood pressure. 
The considered gold standard treatment is the continuous positive airway pressure (CPAP) given in 
attempt to improve daytime sleepiness, cognitive function, daytime mood and reduce blood pressure, 
but its levels of compliance are poor associated with side effects and high rate of abandonment. Yet, its 
minimal therapeutic usage is still unknown and improvements are needed [3]. Moreover, its effect on 
blood pressure is a subject of controversy in the scientific community [2] being claimed to reduce 
daytime sleepiness and the risk of cardiovascular morbidity and mortality in the most severely affected 
patients but not for moderately affected ones for whom CPAP therapy may not be suitable [4]. 
Alternative methods have been proposed like the practice of some instruments like didgeridoo which is 
claimed to be an effective alternative treatment, well accepted by patients with moderate obstructive 
sleep apnea syndrome due to the training of the muscles of the upper airways, which control airway 
dilation and wall stiffening [4]. Other treatment approaches are available, such as the oral appliance 
therapy and the mandibular advancement devices (MAD), that are considered less cumbersome than 
CPAP. Nevertheless, these devices also show side effects and their efficacy strongly depends on the 
morphology of the patient. 
Finally, SAS is also associated with an increased risk of cardiovascular diseases, especially hypertension. 
However, the evidence that SAS is an independent risk factor for cardiovascular disease or death has 
been disputed and although the overall mortality rate of patients suffering from SAS was similar to that 
of the normal population, patients with SAS who had been prescribed CPAP therapy died mainly form 
cardiovascular diseases [5]. Consequently, if we consider sleep apnea syndrome as an independent 
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cardiovascular risk factor, effective therapy would considerably decrease the development of these kind 
of diseases. 
The above paragraphs underline the fact that there is still a large portion of the SAS population that 
remains inadequately treated or even untreated. The development of non-invasive SAS treatment 
methods, with improved acceptability is thus of major importance[6]. Moreover, an exhaustive study of 
the effects of these therapies on cardiovascular response is of high importance. 
In this project, we are going to study the effect on cardiorespiratory response modulated by autonomic 
nervous system to the implementation of PASITHEA’s device developed by Laboratoire de Traitement 
du Signal et Image (LTSI), which has already shown to cause a beneficial effect of reducing the duration 
of apnea and hypopneas in obstructive sleep apnea syndrome patients. 
1.1. Aims of the project 
The SEPIA team from the Laboratoire de Traitement du Signal et Image (LTSI) has been collaborating 
with the Sorin Group society and with the Centre Hospitalier Universitaire (CHU) from Grenoble to 
develop a pilot clinical study, which allows to evaluate a monitoring and therapeutic system for sleep 
apnea syndrome patients. The acquired database is rich in information about nervous system’s response 
in this population and several encouraging results have been obtained. The main goal of the project is to 
develop a new analysis focused on the interaction between respiratory and cardiovascular systems [7].  
1.1.1. Main aim  
Regarding our background, the main goal of the project is to develop a new analysis focused on the 
interaction between respiratory and cardiovascular systems to be able to determine the effect on 
vasoconstriction of the therapy proposed by PASITHEA. 
1.1.2.  Specific aims 
More precisely, the specific goals of the project are the following ones: 
• Study and analyse the clinical problem and its physiological cause as well as the database 
structure acquired. 
• Study of signal processing methods developed previously in the team to propose techniques to 
extract information and characteristics of the acquired database. 
• Development of statistical analysis from extracted parameters from the database in order to 
study the autonomous response associated with the level of disease. 
Autonomic nervous system response analysis in patients suffering from sleep apnea syndrome 
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• Detailed development documentation. 
1.2. Scope of the project 
PASITHEA project has a life of five years, during this time the research team has been working on 
several studies such as the detection accuracy of the respiratory events, the effect on the sleep stage and 
autonomous response regarding Oxygen Saturation (SO2). The main objective of this project is to extract 
response features regarding Pulse Transit Time (PTT) and Pulse Photoplethysmography Amplitude 
(PPG). 
Obtaining these parameters, we try to understand which are the effects of stimulation on autonomic 
response and the changes of parasympathetic response to sleep apnea and hypopnea.  
These studies will be carried on with the data from the database, more precisely, with the 
electrocardiographic (ECG) and pulse photoplethysmography (PPG) signals from 20 patients. After 
obtaining the desired characteristics we will carry on a statistical analysis to determine whether the 
obtained results are significant.  Once we have all our processed data, we will be capable of determining 
our therapy effect on cardiovascular system. 
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2. Project Background 
2.1. Laboratory of Signal and Image Processing (LTSI) 
The Laboratory of Signal and Image Processing (LTSI - INSERM U 1099) is a research laboratory in 
science, technology and health information created in 1969. It is under the supervision of the National 
Institute of Health and Medical Research (INSERM) and the University of Rennes 1. 
More than one hundred people work in the laboratory, whose studies are conducted by 5 teams: 
▪ SESAME: It works on the neural systems responsible for epileptic seizures. 
▪ SEPIA: Focus on monitoring, explanation and prevention of heart failure and apnea bradycardia. 
▪ MetriQ: Its main aim is to develop methodology and instrumentation methods in the field of 
nuclear magnetic resonance. This area includes the magnetic resonance imaging (MRI) and 
magnetic resonance spectroscopy (MRS). 
▪ IMPACT: It works on the therapeutic and surgical assistance by the image. This work concerns 
in particular the cardiovascular and the oncology field. 
▪ MEDICI: focused on the development of models and informatic systems to improve decision 
making in surgery. 
The SEPIA team, in which this project has been performed, is a global leader in its field. Among its 
members, we can find clinical investigators, researchers in engineering, cardiologists and paediatricians 
of the University Hospital Centre (CHU) Pontchaillou. It also has academic partnerships such as the 
University of Sherbrooke, Canada and the Clinical Research Institute of Montreal which provides 
experimental animal models (sheep and pigs) [7].  
This team responds to clinical problems by: 
▪ The development of new cardiac “smart” devices. 
▪ The observation of the autonomic nervous system. 
▪ Monitoring of apnea-bradycardia, severe discomfort and sudden death syndrome in infants. 
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2.2. PASITHEA 
The PASITHEA project, led by Alfredo HERNANDEZ, INSERM research director of SEPIA team, 
integrates an industrial partner (SORIN GROUP), and two French hospitals (CHU Rennes, CIC-IT 
Rennes and Grenoble University Hospital) [8].  
The main goal of PASITHEA project is to find a new system of detection, monitoring and treatments of 
SAS by means of adaptive kinaesthetic stimulation, improving apnoeic patient care and simplifying the 
diagnosis. The hypothesis underlying this therapy is that a controlled kinaesthetic stimulation can 
activate subcortical centres that control the upper airway muscles without generating cortical arousal, so 
the breathing resumes without respiratory events associated with SAS. 
This project has been entitled “Personalized and Adaptive kinaesthetic StImulation Therapy, based on 
cardio-respiratory Holter monitoring for slEp Apnea syndromes” (PASITHEA). The system is 
composed of three main components [9]: 
a. A cardiorespiratory ambulatory recorder (Holter), providing data acquisition and wireless 
transmission of the acquired data in real time. 
b. A kinaesthetic stimulation system, comprising a stimulation signal generator and a kinaesthetic 
actuator, typically positioned behind the ear. 
c. A control device for adaptive kinaesthetic stimulation which will be embedded, in a first phase, 
into a computer. 
These three components interact using a specific wireless communication protocol, based on Bluetooth 
(BT) technology. We can find a schema of the device in Figure 2.1 for an easier comprehension. In 
Figure 2.2 the first prototype of PASITHEA’s device is showed. 
2.2.1. PASITHEA’s device 
The device provides a new system for detection, monitoring and treatment of SAS, directed to improve 
patient management by integrating both a real-time diagnostic approach and a better treatment tolerance 
that may improve long-term observance.  
2.2.1.1. Cardiorespiratory Holter  
A commercially available Sorin Holter system was modified by partner SORIN CRM in order to meet 
the requirements of the project. The new cardiorespiratory Holter prototype is capable of acquiring and 
locally recording two ECG channels (sampling frequency: 256 Hz, resolution 10µV, frequency 
response:0.05-80Hz), nasal pressure (sampling frequency: 256 Hz) and blood oxygen saturation (SaO2) 
Autonomic nervous system response analysis in patients suffering from sleep apnea syndrome 
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(sampling frequency: 1Hz) during a whole night. This system can also transfer these data in real-time 
(every 100ms) through a Bluetooth Low Energy (BTLE) link towards the real-time signal processing 
application for further processing [9]. 
 
Figure 2.2 General diagram of PASITHEA system showing its main 
components: 1) Cardio-respiratory Holter, 2) Kinaesthetic stimulator, 
3) Real-Time application for data processing and control. 
Figure 2.1 Prototype of the cardiorespiratory Holter device with associated 
sensors: ECG electrodes, SaO2  ear sensor and nasal pressure cannula. 
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2.2.1.2. Kinaesthetic stimulation system 
The kinaesthetic stimulation system has been developed by LTSI, based on previous prototypes already 
used for kinaesthetic simulation therapy for apnea-bradycardia on preterm new-borns. The system 
consists in a command module and a kinaesthetic actuator. 
The command module is a battery-operated device that can generate dynamic stimulation signals in an 
adaptive fashion. This module is based on an ATmega168 micro-controller, embedding a custom, multi-
agent software that handles all the functionalities of the device. In particular, the micro-controller can 
synthesize sinus signals with varying amplitudes and frequencies, to be presented as input to a driver 
circuit that will handle the kinaesthetic effector. The command module can function either in an 
“autonomous” or a “slave” mode. The slave mode requires establishing a BT connection with a master 
system (in this case, the real-time control application) that will command the operation of the stimulator. 
The stimulating device is a resonant linear actuator with optimal resonance frequency of 175 Hz (model 
C10-100, Precision Microdrive Ltd, London, UK). At 100% of the acceptable input signal amplitude 
(2VRMS), this actuator generates a typical normalized acceleration of 13.7 m/s2 [9]. 
2.2.1.3. Real-time processing and control application 
This application, is in charge of establishing wireless communication links with the Holter and the 
stimulator, receiving data from the cardio-respiratory Holter, performing real-time signal processing on 
the received signals for the detection of apnea or hypopnea episodes and according the detector’s output, 
apply the proposed “on-off” controller and send the appropriate command to the kinaesthetic stimulator 
through a Bluetooth (BT) link [9]. 
2.2.1.4. Wireless communications and data acquisition 
The control application establishes wireless BT links with the Holter and the stimulator device and 
performs device initialization and management using specifically developed application-level 
communication protocols. Methods of error correction and verification of the integrity of the BT links 
have been integrated in the protocol and are also handled by the control application. Data acquisition is 
initiated and terminated by the application and all available signals are received in real-time from the 
device at their original sampling rates [9]. 
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2.2.1.5. Real-time respiratory event detector 
The respiratory event detector is based on the segmentation of respiratory cycles from the acquired nasal 
pressure signal. A full respiratory cycle is defined as inhalation followed by exhalation. Inhalation is 
detected when the nasal pressure signal exceeds a positive threshold value (λI(t)). Exhalation is detected 
when nasal pressure signal falls below a negative threshold value (λE(t)). Both thresholds are updated 
independently, through time, according to the patient’s breathing patterns. An apnea is detected as the 
absence of inhalation for more than 3 to 10 seconds (Δaϵ [3, … ,10] s). A hypopnea event is detected 
when inhalation amplitude falls below 50% below inhalation baseline for more than 5 to 10 seconds (Δhϵ 
[5, … ,10] s). However, some additional criterions were added [9]: 
▪ For apnea detection: an apnea was detected not only as the absence of inhalation for a certain 
time but also as a “flat” breathing line, i.e. nasal pressure amplitude had to stay within the 
inhalation and exhalation thresholds. 
▪ The time to detect apnea (Δa) was not a fixed parameter but would be set, within limits, as the 
average of the patient’s latest respiratory cycle periods. 
▪ The time to detect hypopnea (Δh) was not a fixed parameter but linked to the amplitude of 
inhalation drop: a quicker detection for severe hypopnea (with large drop) and a slower detection 
for less severe hypopnea. 
2.2.1.6. Control of the kinaesthetic stimulation 
In this first version of PASITHEA system a real-time “on-off” control method was implemented into 
the application, using as control variable detector’s output. When respiratory event detection is 
confirmed, around 8 s after the beginning of the respiratory event, a command is sent to the kinaesthetic 
stimulator to activate it. Although the system is able to apply different stimulation strategies for different 
types of respiratory events, during the acquisition of our database we used the following characteristics: 
A constant amplitude is applied to the patient at a frequency of 175 Hz. Kinaesthetic stimulation is 
organized into bursts of a maximum duration of 3 s each, followed by a silent period of 2 s. A maximum 
of 3 bursts were applied in a given detected respiratory event. This burst-based stimulation is applied in 
order to minimize patient habituation to the stimulation as well as the fragmentation of the patient’s 
sleep. When the detector confirms the end of the respiratory event (first detected deflection on the nasal 
pressure signal above a given threshold during a respiratory event) a command is sent to stop kinaesthetic 
stimulation [9]. 
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2.2.2. Data acquisition and patient population 
The followed protocol has been approved by the ethics committee of the Grenoble University Hospital 
(HYPNOS study), and involving five centres: The University Hospitals of Angers, Grenoble, 
Montpellier, Rennes and Tours. The first objective of this study is to validate the autonomous response 
to device’s stimulation. 
After signing an informed consent, all patients underwent a full polysomnography (PSG) in a sleep 
laboratory. Nasal pressure (NP), electrocardiography (ECG) and oxygen saturation (SaO2) were 
simultaneously acquired and processed by the PASITHEA system. Using a t-deviation tube, the same 
nasal pressure was presented as input to the sensors of both the cardiorespiratory Holter and the PSG 
systems. Central reading of PSG was performed by an expert, blinded core-lab (CHU Grenoble France) 
who provided the overall Apnea Hypopnea Index (AHI) together with an accurate scoring of individual 
events (start, duration and type of event) for each patient. 
A total of 46 severe obstructive apnea (OSA) patients (mean age: 58.5, BMI: 30.1 kg/m2, AHI: 47.7/h – 
with 92% of obstructive events, 75% male) were included in this study. 12 patients were included in a 
titration phase, dedicated to optimize the parameters of the respiratory event detector and to establish the 
amplitude of the kinaesthetic bursts that were used for the rest of the study. The 34 remining patients 
were included on the study phase, with a fixed stimulation amplitude of 80% of the maximum power of 
the stimulator (normalized acceleration of approx. 11m/s2). This stimulation amplitude value was 
determined during the titration phase. 4 patients were totally excluded from the analysis due to problems 
with de PSG recording, or to a bad nasal cannula signal, preventing correct detection of respiratory 
events. Additionally, 4 other patients were excluded from the therapy analysis because the stimulation 
therapy was not delivered (failure of the stimulator cable or connector), 6 other patients were excluded 
due to the absence of ECG recording. Finally, 20 patients are available for the analysis of the therapy 
[9]. 
2.2.3. The Database 
 
LTSI provided HYPNOS database with all the signal acquired during the polysomnographic studies of 
the patients. They were 8 hour-length signals. The ones used along this study are the ones described in 
Table 2.1. In the first place, we have electrocardiographic signal (ECG) from standard 
polysomnographic study, which was recorded in µV. The next signal we can find is the respiratory signal 
(DEB), extracted with a t-deviation cannula and measured in µV. In third the place, we have the 
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stimulation signal (SKIN) which gives us information about the kinaesthetic stimulations received by 
the patients and its amplitude. The fourth signal we have is the pulse photoplethysmography obtained 
from the polysomnographic study in µV. And, to end, we have the information about stimulated and 
non-stimulated cycles in CyclesOnOff. Each recording started with an initialization segment of 60 
minutes during which no stimulation was delivered, in order to let the patient to fall asleep. After this 
period, the therapy evaluation is started, by defining consecutive periods in which the stimulator was 
active for 30 minutes, followed by inactive periods of 30 minutes, so that each patient represents its own 
reference.  
 
Signal Description 
ECG Electrocardiographic recording in µV. 
DEB Respiratory signal recorded in µV. 
SKIN Stimulatory signal recorded in µV. 
PULSE Pulse photoplethysmographic signal recorded in µV. 
CyclesOnOff Information about the beginning and the end of each stimulated and non-
stimulated cycle 
 
Table 2.1 Database signal description.  
 
2.3. Related Physiology 
In this part of the project the physiology related to our analysis is described. First, starting with a brief 
description of what is the Autonomic Nervous System (ANS) to be able to understand the related 
mechanisms. Followed by the definition of sleep apnea and hypopnea, which is the base of our study.  
And, finally, the physiological response to respiratory events. 
2.3.1. Autonomic Nervous System 
The autonomic nervous system plays a major homeostatic role in the regulation of the “milieu intérieur”. 
Control of the ANS is complex, but fundamentally it functions on reflex arcs which may be modulated 
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by a variety of inputs. Despite its name, it is not “autonomic”, being regulated by centres in the central 
nervous system, particularly the hypothalamus. It essentially acts as a motor system undertaking a large 
number of specialized tasks, both stimulatory and inhibitory, in a wide range of target organs, tissues, 
blood vessels, glands and even single units such as mast cells. Closely associated with the efferent nerves 
is a complex network of afferent fibres like sensory chemoreceptor, mechanoreceptor, nocioceptor, 
thermoreceptor, baroreceptor and osmoreceptor signals back to central nervous system (CNS) centres 
where the complex homeostatic reflex arcs are regulated. The ANS can be divided into three divisions 
based on anatomical and physiological considerations. The sympathetic division forms the major part of 
the ANS innervating more structures than the parasympathetic system. The parasympathetic division 
arises in the brain stem and supplies the seventh, ninth and tenth cranial nerves. The heart, lungs and the 
abdominal viscera are served by preganglionic fibres distributed by the vague nerve. There are also large 
numbers of afferent parasympathetic fibres which outnumber the motor fibres and feed-back the 
multitude of sensory signals necessary for homeostasis. The enteric division is made up of the nerves 
and ganglionic plexuses that are found in the walls of the gastrointestinal tract, gall bladder, and within 
the pancreas. It forms a complicated meshwork of sensory, motor and interneuronal components that 
uses a diverse array of neurotransmitters. 
The enteric nervous system is largely pre-programmed to produce the classical peristaltic movements 
associated with each section of the gastrointestinal tract, but its effects are modified by local reflex arcs, 
extrinsic autonomic input, hormones and immune mediators [10]. 
In Figure 2.3 we have a description of the sympathetic and parasympathetic divisions of ANS as well as 
the organs and mussels they act on. 
Along this project, we are going to focus on the sympathetic and parasympathetic divisions. To be able 
to determine and successfully understand which is the effect of our therapy we have to know the 
functions that each division of ANS develop. In first place, sympathetic division is the one that prepares 
our body for the called “fight or flight”, which means that prepares our body for stressful or emergency 
situations by means of increasing heart rate and forcing heart contractions, releasing energy stored in the 
liver, increasing the speed at which energy is used to perform body functions, increasing muscle strength, 
widening the airways to make breathing easier, increasing transpiration, decreasing digestion and 
urination and controlling the release of semen ejaculation. On the other hand, parasympathetic division 
controls body process during ordinary situations, conserves and restores. Its main functions are to 
stimulate the digestive tract to process food and eliminate wastes, slow heart rate, reduce blood pressure 
and control erections [11]. 
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Figure 2.3 The sympathetic and parasympathetic divisions of ANS [10]. 
 
2.3.2. Sleep Apnea Syndrome 
Sleeping is a physiologic process which enables the body to reset and obtain energy to start a new day. 
However, 30 years ago, approximately, it was found that the disordered and even disrupted breathing 
during sleep is a substantial medical problem. Inside the so-called Sleep Apnea Syndrome (SAS) there 
are several types of disorders.  
The most common one is Obstructive Sleep Apnea Syndrome (OSAS), affecting more than 10% of the 
population over the age of 65 [12]. In this condition, the tone of the upper-airway musculature is 
inadequate to maintain airway patency. When the upper airway is floppy, the anatomical structures of 
the upper airway are drawn into the airstream as the diaphragm descends and obstruct inspiratory airflow. 
The second most common disorder during sleep is Central Sleep Apnea (CSA), which is also a loss of 
inspiratory airflow, but it occurs because of a loss of phasic diaphragmatic activity. 
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And, in third place, we have Hypopneas, which are breathing events which are lower than normal ones. 
In Figure 2.4 the different abdominal motion for each type of apnea can be observed.  
These events may recur hundreds of times in a single night with serious health implications. The 
resulting sleep fragmentation and blood gas modifications cause malfunctions of sleep-related 
restorative processes, and induce chemical and structural injuries in the cells of the central nervous 
system. Not only it cause daytime sleepiness, it can lead to systemic hypertension and increase in the 
likelihood of cardiovascular diseases [13]. Nonetheless, treatment to restore breathing during sleep can 
prevent these consequences. 
 
 
2.3.3. PPT and PPG response to respiratory events during sleep 
As seen in previous parts, physiological responses are dependent on autonomic nervous system. So, to 
be able to relate all the concepts we have to start defining the following ones: 
PPG (Pulse Photoplethysmography): Simple optical technique used to detect volumetric changes of 
blood in peripheral circulation. It is a low cost and non-invasive method used to take measurements at 
the surface of skin. The technique provides valuable information related to cardiovascular system. 
Figure 2.4 Respiratory motion of chest wall with no nasal air flow for obstructive Apnea and Central Apnea.[12] 
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Recent advances in technology has revived the interest in this technique, which is widely used in clinical 
and physiological measurement and monitoring. 
PPG Amplitude: Difference between the value of PPG on the maximal fraction of the peak and the 
lower part of the wave. Used to estimate the skin blood flow using infrared light. Researchers from 
different domains of science have become increasingly interested in PPG because of its advantages as 
non-invasive, inexpensive, and convenient diagnostic tool. Traditionally, it measures the oxygen 
saturation, blood pressure, cardiac output, and for assessing autonomic functions [14]. 
PPT (Pulse Transit Time): Quantitative measure of the time that pulse wave needs for passing from 
one arteria, typically the aorta, to another, typically in the periphery. Evaluated as the time interval 
between the ECG R peak and the corresponding PPG wave [13]. 
When a respiratory event is produced, it causes an increase in the respiratory effort which produces an 
increase in the amplitude oscillations of PTT, which decreases after an apnoeic event due to a 
sympathetic activation related to arousal, which also produces heart rate increment, higher stroke 
volume, vasoconstriction, which in turn generate pulse wave acceleration giving a decrease in PPG 
amplitude [13]. In figures Figure 2.5 and Figure 2.6 we have a diagram of the followed sequence for an 
easier understanding. 
By the stimulation that PASITHEA’s device, the expected response would be an activation of subcortical 
centres which control the upper airway muscles, without generating cortical arousal, which would result 
in a parasympathetic activation, producing vasodilation, decrease of blood pressure and heart rate 
decrement. Which is traduced in minor changes of PTT and PPG amplitude after respiratory events 
regarding its initial situation before the event occurs 
Respiratory 
Event
Sympathetic 
Activation
Heart Rate  
Stroke Volume  
Vasoconstriction  
PTT   ẟ  
Arousal
 
Figure 2.5 Sequence of physiological responses regarding PTT taking place after a respiratory event. 
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Respiratory 
Event
Sympathetic 
activation
Heart Rate  
Stroke Volume  
Vasoconstriction  
PPG 
Amplitude  ẟ  
Arousal
 
Figure 2.6 Sequence of physiological responses regarding PPG Amplitude taking place after a respiratory event. 
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3. Methodology 
Along chapter 3 the proposed signal processing chain used to develop the project is explained. The 
followed methodology can be divided in three big blogs: 
• The first one is ECG signal processing, in which a R-wave detector is implemented and a 
revision of all detections is realised to make sure not to advance with mistaken data to further 
steps. 
• Along the second block we extract PPG characteristics. In first place, we filter the signal by 
means of autonomous learning parameters. Once PPG signal is filtered, its local extrema 
(minima and maxima) are found and corrected to make sure there exist a correlation between 
filtered PPG extrema and R-wave detections as well as a coupling between maxima and minima, 
which means that for each peak there exist a corresponding valley. From the previous output, 
we obtain PPG Amplitude and PTT signals. 
• The signal’s analysis is realised in the third block. The followed method is based on the 
collection of a delta (ẟ) value based on the detection of the four respiratory cycles after a 
respiratory event occurs, however, it will be explained further in this section. With the obtained 
data, a statistic analysis and a Wilcoxon test is produced to validate the significance of the 
obtained results. 
In Figure 3.1 we can find a diagram of the implemented procedures, input and output signals for each 
section. 
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HYPNOSDB
R-wave 
detection
R-wave 
detection 
corrections
Corrected
 R-waves 
positions
ECG
PPG 
Characteristics 
extraction
Autonomous Learting 
Corrections
PPG Filtration
PPG extrema search 
Extrema correction
PTT obtention and resample
PTT and PPG Amplitude 
PULSE
PPG Amplitude 
Analysis
PTT Analysis
Statistic Results 
Wilcoxon Test for 
PPG Amplitude
Statistic Results 
Wilcoxon Test 
for PTT
Respiratory cycles 
detection
Respiratory cycles 
detection
DEB + SKIN
 
Figure 3.1 Diagram of the followed procedures.
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3.1. ECG characterisation 
To start with our analysis, we need to localize the positions of QRS complexes along the 8 hours of the 
recordings. This information is of high importance because it is the raw data we are going to use along 
the project. 
The main aim was to localise QRS complexes, so the easier and more precise method to do it is to 
localise R-waves along the electrocardiographic signal (ECG). The used detector is taken from LTSI’s 
library. It is an updated version of the one used by J.Dumont et al [15] for ECG beats delineation. It is 
based on successive filtering which filters are designed using Remez method. Multiple parameters 
(threshold adjustments, closed-eyes period duration, cut-off frequencies, order of filters, window sizes, 
etc) were optimized for noisy signals using evolutionary algorithms.  
A problem that appeared by the usage of the detector was that it is an external library in C language 
which works at 1000 Hz and our signals had a sampling rate of 1024 Hz. As a result, some detections 
were moved some samples from peak’s position. The implemented solution was to find local maxima 
in a window of 25 samples around the output detection. However, to make sure that all detections were 
correct they were revised one by one, for all patients, with a function which was also from LTSI’s library. 
The aforementioned, provided a graphic interface which let us move wrong detections and position them 
in the correct place as well as navigate along the signal by means of windows of a previously selected 
size. During the correction process, we chose a window of 10000 samples to have a good quality of the 
image and be able to advance faster. When a modification was made, the function saved them 
automatically and returned the input detection vector with the same name and length but with the 
previously modified data. 
The process of correcting all subjects’ R-wave detections was very tedious, it involved 8-hours signals 
for 20 patients. However, it was a crucial part of the project because, due to interpersonal differences 
and different used calibration while acquiring the data caused some misdetections. Being sure of having 
correct R-wave detections was very important for PTT analysis because it is one of the basic parameters 
needed to obtain it. 
Once we had extracted the positions for R-waves from ECG signals we could move on to the next block 
of analysis, PPG characteristics extraction. 
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In Figure 3.2 we can find an example of the window size used to correct R-wave position detections. It 
can be observed that it is of a sufficient size which allow us to see properly signal characteristics, but at 
the same time allow as to advance along the signal with a proper rhythm. 
  
3.2. PPG characterisation 
In this subchapter of the methodology we are going to explain which PPG’s characteristics were obtained 
and which procedures were implemented. 
First of all, in order to be able to obtain the desired variables from our PPG signals, we have to condition 
them. That means developing a filtering process to extract noise and interferences which can lead to 
wrong detections and false our final results.   
The first step in the signal characterisation was to filter PPG signal. When processing a signal what we 
look for is to delete the noise and interferences contained. Nevertheless, is of high importance to maintain 
a compromise of signal/noise because it is really easy to ruin other parts of our signal containing valuable 
information.  
For that reason, we have used an autonomous learning code in which we inserted a signal window of a 
user-chosen length that contained an example of good signal morphology and an example of noise 
Figure 3.2 Used window for the correction of R-wave position detection. 
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morphology. In Figure 3.3 we can find an example of good PPG signal and an example of noise 
morphology inserted in the autonomous learning code. By means of a graphic interface, we could 
classify manually which parts of the signal where the model for good signal morphology and which were 
the example of noise ones. Finally, the code returned us B parameters.  
The main aim of this procedure was to choose a piece of signal which could be used as a standard for all 
patients, however, due to the different calibrations during data acquisition and interpersonal differences 
there were some signals for which individual parameters had to be obtained.  
B parameters were used as polynomial values to develop a polynomial interpolation that resembled PPG 
wave signal. The polynomial interpolation was compared to the original signal. There also was a 
minimum percentage of similarity which we fixed to 90% after several performance observations. If the 
similarity percentage was lower, the piece of the signal which diverged was deleted. In Figure 3.4 we 
have an example of filtered signal due to its saturation. 
Then, we needed to localize pulse waves. The easiest and more robust method was to detect its local 
maxima. As PPG signal is really constant and it was already filtered we did not have major problems 
due to wrong detections, however, random checks were done to ensure the reliability of the analysis. 
To find PPG amplitude we found wave peaks and valleys to have maximum and minimum values. 
Despite the fact that having the aforementioned data, we could not obtain PPG amplitude values yet. To 
Figure 3.3 Example of good PPG signal and noise for the autonomous learning codes. 
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do so we needed to coordinate peak values with valley ones in order to obtain the amplitude for each 
wave. For that, we considered the detection of a wave when a local maximum was found and it was 
coordinated with its corresponding following local minima. This coordination was made with a very 
easy procedure, for every peak detection a window was opened from the present numerator to de 
following one and local minimum was searched within these values. The resultant vectors had each peak 
and the corresponding valley in the same vector index, they were paired. 
In addition, PPG peaks were coordinated with R-wave detections. That means that for each removed 
segment of PPG signal, R detections corresponding to that segment of the signal were deleted as well. 
As previously done for local extrema, pulse peaks and R-waves were coordinated. That means that for 
every R-wave detection a window was created from that detection to the following one and PPG peaks 
were searched and stored in the same vector number as the corresponding ECG wave. The result was 
that for every detected R-wave we must have a PPG peak behind it, and for each PPG peak there must 
be a R-wave detection in front. This procedure eased considerably our analysis. In Figure 3.5 we have 
an example of R detections, PPG peaks and valleys coordination. 
Once we had all basic characteristics, we pursued to extract the values of times when R-waves and PPG 
peaks took place. From them and as all data was linked, we were able to extract pulse transit time (PTT), 
as showed in Eq. 1Figure 3.5, with the following simple operation: 
Figure 3.4 PPG filtration example. 
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𝑃𝑇𝑇 =
𝑃𝑃𝐺 𝑝𝑒𝑎𝑘
𝑓𝑠
−
𝑃𝑃𝐺 𝑝𝑒𝑎𝑘
𝑓𝑠
 
Eq. 1 
 
R-R interval was also calculated as showed in Eq. 2: 
𝑅𝑅 = 𝑅(𝑖) − 𝑅(𝑖 − 1) 
Eq. 2 
 
PPG amplitude was calculated in the following way: 
𝑃𝑃𝐺𝐴𝑚𝑝 = 𝑀𝑎𝑥 − 𝑀𝑖𝑛 
Eq. 3 
 
For PTT, RR and PPG amplitude a correction was necessary due to their length. As they were extracted 
from specific points of the signals they needed to be resampled so that their total length was the same as 
the original signal one. 
Once we extracted all desired parameters we saved them and kept them to realise the following analysis 
for PPG amplitude and PTT. 
Nevertheless, we were given a PTT calculation by the polysomnography from a patient. We compared 
it with the one we extracted to make sure our method’s performance was acceptable.  
After the comparison shown in Figure 3.6, we can be confident that our PTT extraction was completely 
satisfactory and it had even less noise that the given one.  
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Figure 3.5 R-wave, PPG peaks and valleys coordinaion with an example of the extracted PTT 
for that window. 
Figure 3.6 Comparison between found PTT and given PTT which proves our improvement. 
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3.3. PTT and PPG Analysis 
Once all necessary characteristics were extracted, we proceed to its analysis. Our main aim was to find 
the parasympathetic response on cardiovascular system due to a kinaesthetic stimulus after a respiratory 
event detection. For this reason, we are going to analyse changes in Pulse Photoplethysmography 
Amplitude (PPG) as well as in Pulse Transit Time (PTT). The same method was used for both 
parameters, for this reason it will only be explained once in the project. 
These analyses were divided in three main parts: 
• Sleep information  
• PPG/PTT Analysis 
• Disclosure 
3.3.1. Sleep Information 
The goal of this step is to extract useful information about all respiratory events that took place during 
the recording of the signals helped by the annotations developed by the doctors who analysed them 
previously. 
At the beginning of it, as in all procedures, we got real data from original signals. Then, stimulation 
signal (SKIN) was filtered with a butterwort bandpass filter between 160-190 Hz. From the annotations, 
we could classify the respiratory events between apnea or hypopneas as well as determining its start, end 
time and position along the respiratory signal. 
Right after, excluding rules were imposed so as to have a better classification of each event. These rules 
were extracted from the clinical annotations made by doctors and provided to the lab. 
Finally, all apnea and hypopneas are checked simultaneously with SKIN signal to determine whether 
they were stimulated. For that reason, we took a window of SKIN signal from the start of the event to 
the end of it plus three seconds, which is the time it can take to detect that an event is taking place. 
To end, we save all data to go on with our analysis. 
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3.3.2. PPG Amplitude and PTT Analysis 
Is in this section where we are going to use all data extracted previously in the project and we are going 
to conduce PPG amplitude and PTT main analysis to see the vasoconstrictive response to kinaesthetic 
stimulation. 
In a primary state of our analysis, we tried several methods based on the mean values of PPG Amplitude 
and PTT after apnoeic and hypopneic events. After obtaining the results for the corresponding statistic 
analysis and Wilcoxon test comparing stimulated event to not stimulated, no significative values were 
obtained so we decided to carry on a more exhaustive method based on the analysis event per event.  
The chosen analysis method is based on delta calculation between the signal before and after each 
respiratory event. In first place, we calculate the mean value of the signal from 10s before the start of the 
event to the start of the event. This way we obtained a reference value. 
Eq. 4 
𝑅𝑒𝑓 = 𝑆(𝑠(𝑖) − (10 ∗ 𝑓𝑠): 𝑠(𝑖)) 
Being S the analysed signal (PPG or PTT), s the vector which contains the sample number at which the 
event start, i the number of event we are analysing, fs our sampling rate and Ref  the reference value we 
are looking for. 
Following J.Pagani et al. [16], we are going to use the length of four respiratory cycles after the end of 
the event to analyse the effect on the signals. Defining a respiratory cycle as the piece of signal detected 
from the detected intersection point in the ascending wave (inhalation) to the same point in the following 
wave. We have chosen four of them because it was the average respiratory cycles we could find in our 
signals. Moreover, we have just used signals which actually had this number of cycles for a more 
accurate analysis. These cycles were detected by means of a function which returned the positions of the 
beginning of the first and the end of the fourth respiratory cycle for apnea and hypopnea separately. This 
function will be commented in the following section. During the period of time between detections the 
minimum value of the analysed signal was searched and saved under the name of inc.  
Eq. 5 
𝑖𝑛𝑐 = min (𝑆(𝑟1: 𝑟4)) 
Being r1 the beginning of the first respiratory cycle and r4 the end of the fourth respiratory cycle. 
Finally, to have our delta value we subtract inc value to Ref  as showed in Eq. 6.  
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           Eq. 6 
𝛿 = 𝑅𝑒𝑓 − 𝑖𝑛𝑐 
Where 𝛿 is the delta value we were looking for. In figure Figure 3.8 and Figure 3.7 we have a graphic 
representation of delta method for a stimulated and non-stimulated event, for PPG amplitude and PTT. 
 
ẟ 
  Cycle Start 
 Cycle End 
 inc 
 Ref  
Figure 3.7Delta method for non-stimulated hypopnea on PPG Amplitude signal. 
ẟ 
  Cycle Start 
 Cycle End 
 inc 
 Ref  
Figure 3.8 Delta method for a stimulated hypopnea for PTT. 
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Running this procedure for all patients and all events we obtained the necessary input data to develop 
the statistical analysis. For each patient, we extracted the mean delta value for apnea and hypopnea, 
standard deviation, median value, Q1 and Q3. To determine whether the obtained results were 
significant, we carried on a Wilcoxon test the output of which must be p<0,05 to be considered as 
significant.  
Regarding the theoretical background, when an hypoxia (diminished availability of oxygen to the body 
tissues.) takes place, there is an increase in sympathetic activity causing vasoconstriction, which is 
reflected in pulse photoplethysmography (PPG) signal by decreases in the signal amplitude 
fluctuation[17], as we could observe in the previous figures. Moreover, pulse transit time (PTT) 
decreases after an apnoeic event due to a sympathetic activation which produces heart rate increment, 
higher stroke volume, and vasoconstriction, which in turn, generate pulse wave acceleration[13]. 
Regarding this information, our hypothesis is that our therapy must avoid the effect of respiratory events, 
which means that the obtained increment value is not significantly higher or lower in relation to the 
reference one for stimulated events. For this reason, we developed the Wilcoxon test in both right and 
left senses to find in which patients the stimulation had no effect (signal decrease) or had a too 
meaningful effect (signal increase). 
The results of the Wilcoxon test can be found in the corresponding section of Results chapter, the result 
to the statistical analysis can be found in Tables A1-A4 in the Annexes. 
 
3.3.3. Disclosure 
The main aim of this part of the was to produce plots of each respiratory event of each patient to be able 
to produce a random check of the performance of the implemented method. In these plots, we 
represented the respiratory signal with indications of start and end detections of the respiratory events, 
stimulation signal and PTT/PPG amplitude signal. Both respiratory and PTT/PPG Amplitude signals 
have represented the limits of the windows used along the method. 
With this graphical representation, we can determine if the detections were accurate and whether the 
obtained results were right. To this extent, we could consider these plots as check ones. 
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In the following figures (Figure 3.10 and Figure 3.9), we can find an example of these plots which were 
used to follow the development of our analysis. 
  
Figure 3.10 Check plot for subject FRGNB4IAHO02012 hypopnea 63, PPG amplitude analysis. 
Figure 3.9 Check plot for subject FRGNB4IAHO02012 hypopnea 14, PPG amplitude analysis. 
  Report 
30   
Finally, the most significant extracted parameters are saved in order to upload them in LTSI’s database. 
From each ECG signal we extracted the RR series, R-wave detection and PTT with coordination of PPG 
signal, from which PPG amplitude was extracted. 
ECG
R-wave detections
RR series
PTT
PPG
PPG Amplitude
 
Figure 3.11 Precedence of the stored data in LTSI's database. 
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3.4. Respiratory Cycles detection 
Normally, functions are not explained because they are not of high importance in the analysis 
development, however, the implementation of this one plays a key role in our project because it provides 
not only the detections of the beginning and the end of the respiratory cycles, but also selects the 
respiratory events after which we can find the number of desired cycles. Before creating the function to 
detect respiratory cycles, the periods were detected by means of findpeaks MATLAB command. 
However, as the signal was not uniform, had a really high sample frequency and had different 
characteristics depending on the patient and on the data acquisition calibration, the resultant output data 
contained lots of mistakes. 
In order to develop a robust function, we have to make sure it gets the correct detections. To achieve it, 
our program analyses a window of the input signal which goes from the sample where the respiratory 
event ends to 25s after as it can be observed in Eq. 7. This value was taken knowing that the average 
duration of a cycle is 2s and during sleep it is longer, anticipating the fact that in-between cycles we can 
find a respiratory event which will create a longer duration.       
Eq. 7 
𝑊 = 𝑆(𝑒(𝑖): 𝑒(𝑖) + (25 ∗ 𝑓𝑠)) 
Where W is the window, S is the signal we were processing, e is the end of the respiratory event, i is the 
counter of events and fs is the sampling rate. 
Afterwards, we calculate the mean value of the samples contained within the window. This value will 
be very useful because we used it as a threshold value in the following step. Having obtained the mean 
value, we looked for the points in which the respiratory signal crossed the threshold, in other words, for 
which samples the actual value was lower than the threshold and the next one was higher or vice versa.  
To get rid of fake detections caused by signal noise, we imposed the condition that consecutive 
detections must be separated by a distance of the 30% of the sampling rate. That means that at least a 
respiratory cycle must last 0,3 s. We took such a low value because it has been observed that many times 
after an apnea takes place the patient realises a very quick inspiration which we have also counted as 
respiratory cycle. These quick cycles are a result of the attempt to restore normal breath after an apnea 
or hypopnea. 
Once all intersections are detected, we made sure that at least 9 points were detected, 4 respiratory cycles. 
Afterwards, all found intersections were classified as ascendant, assigning them a 1, or descendant, 
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assigning them a 0 in a check vector. Perfect detections would have a special pattern in their check 
vector: [1 0 1 0 1 0 1 0 1]. Given that, we looked for this motif in the check vector and saved the position 
of the first detection and the position of the last one. In Figure 3.12 we can find an example of the output 
window taken as a result of the detection of the beginning of the first cycle and the end of the fourth. 
Although this is the main detection method, due to interpersonal difference and non-identical data 
acquisition calibration, some special-case-mean modifications had to be included in the code. This way 
we increased the number of correct detections and decrease missed ones.  
The first special case introduced was focused on the events when the mean window value is found in a 
zone with lots of noise. In these cases, the best solution was to lower the threshold value 15 µV so that 
the threshold found a cleaner signal zone. This value was determined empirically from disclosure 
observation. By doing it, we got rid of the problematic areas and it was easier for our program to establish 
correct detections. In Figure 3.13, Figure 3.14 and Figure 3.15 the benefits of the implementation of the 
particular-case methods can be observed. 
 
Figure 3.12 Example of output detection of the begining of the first respiratory cycle and the end of 
the fourth. 
Cycle Start 
Cycle End 
Mean 
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Figure 3.13 Intersection detections with basic respiratory cycles method. 
Figure 3.14 Intersections detections with respiratory cycles particular-case method 1. 
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The second particular-case method introduced was for those windows which contained relatively high 
maxima and low minima and as a result their mean value was located in a zone of signal instability. For 
that reason, the proposed solution was to multiply the mean value for 2.5 and move it to a cleaner zone. 
This value was also stablished after check plots observation.  
Moreover, the distance between intersections was also increased to the 40% of the sampling rate. Its 
reason why was because the points would be localized in the ascending or descending part of the wave 
so, theoretically, they would be positioned further apart one from each other. In the following figures 
(3.16-3.18), we can find an example: 
 
 
 
 
 
 
Figure 3.15 Output window after detecting correctly the four respiratory cycles. 
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Figure 3.17 Detections of respiratory cycles for particular-case method 2. 
Figure 3.16 Intersection detections using basic respiratory cycles detector method. 
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Figure 3.18 Output window from the respiratory cycles detection function using 
particular-case method 2. 
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4. Environmental impact 
analysis 
This chapter will talk about the environmental impact of the project, which means the consequences 
from a wrong usage, a bad function of the presented device in PASITHEA’s objectives or a wrong 
analysis carried on.  
As previously said in the introduction, PASITHEA’s device is presented as a new therapy to Sleep 
Apnea Syndrome (SAS), which is a multifactorial disease characterized by repeated episodes of 
breathing pauses (apnea) or significant reductions in respiratory amplitude (hypopnea) during the 
patient’s sleep The sleep apnea syndrome (SAS) has a prevalence in middle age of 2% in women and 
4% in men [1] and has a high impact in populations suffering from cardiovascular diseases and type 2 
diabetes (long term metabolic disorder characterized by high blood sugar, insulin resistance, and relative 
lack of insulin), where the presence of SAS increases the risk of complications.  
Patients suffering from SAS show apnea or hypopnea episodes that can be repeated from 5 to 100 times 
per hour of sleep, with durations ranging from 10 seconds to several minutes, strongly affecting the sleep 
structure of the patient. Regarding therapy, the gold-standard treatment is by continuous positive airway 
pressure (CPAP). The CPAP machine delivers a continuous stream of compressed air via a nose or full-
face mask. This positive pressure keeps the airway open and prevents it from collapsing, so that 
unobstructed breathing becomes possible Yet, its minimal therapeutic usage is still unknown and 
improvements are needed [3]. Moreover, its effect on blood pressure is a subject of controversy in the 
scientific community [2] being claimed to reduce daytime sleepiness and the risk of cardiovascular 
morbidity and mortality in the most severely affected patients but not for moderately affected ones for 
whom CPAP therapy may not be suitable [4]. 
Treating SAS is very important as it has a wide variety of side effects which can cause significant sleep 
fragmentation and acute cardiorespiratory responses, that may be deleterious in the long term, being 
associated with higher cardiovascular and metabolic morbidities. Moreover, SAS represent a major 
healthcare issue, affecting more than 5% of the middle-aged population [6].  
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Therefore, new therapeutic solutions are also needed. As a consequence, LTSI has developed this 
method for detecting, monitoring and treatment of SAS to improve the quality of life of people suffering 
from this disease. Different analysis has been carried on and this project is one of them, to discover 
which is the real consequence to stimulation regarding blood pressure changes. A bad performance of 
the device could lead to systemic hypertension and an increase in the likelihood of cardiovascular 
diseases [13]. 
 A bad analysis would provoke a false idea of its effect resulting to be health damaging for the subjects 
who uses it thinking it will improve their quality of life.  
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5. Results 
In this chapter, we are going to present the obtained results of our analysis. Firstly, we show the results 
concerning PPG Amplitude for apnea and hypopnea in different sections not to confuse them. In second 
place, PTT analysis results can be found, and as said previously, apnea results are separated from 
hypopnea ones. Statistic analysis results are not placed in this section, they can be found in the annex. 
5.1. PPG Amplitude results 
In the first place, PPG amplitude results are presented. This are divided in two sections: results for Apnea 
and for Hypopnea. In each section, we will find a table which shows the results of the Wilcoxon rank 
sum test. 
5.1.1. Apnea 
Patients P-Value Apnea 
Right 
h2 Right P-Value Apnea 
Left 
h2 Left 
FRGNB4IAHO02009 0,0206 1 0,9798 0 
FRGNB4IAHO02010 0,3372 0 0,6653 0 
FRGNB4IAHO02012 0,0844 0 0,9308 0 
FRGNB4IAHO02013 0,9588 0 0,0424 1 
FRGNB4IAHO02014 0,4765 0 0,5706 0 
FRGNB4IAHO02015 0,9864 0 0,0154 1 
FRGNB4IAHO02016 0,9167 0 0,1310 0 
FRGNB4IAHO02017 0,3874 0 0,6187 0 
FRGNB4IAHO02018 0,9785 0 0,0221 1 
FRGNB4IAHO02020 0,9643 0 0,0714 0 
FRGNB4IAHO02022 0,6190 0 0,3832 0 
FRGNB4IAHO02023 0,4043 0 0,5993 0 
FRGNB4IAHO02024 0,7568 0 0,2626 0 
FRTRS5IAHO02007 0,7771 0 0,2327 0 
FRTRS5IAHO02010 0,0983 0 0,9122 0 
FRMLR1IAHO02001 0,4465 0 0,5552 0 
FRREN4IAHO02003 0,9170 0 0,0835 0 
FRREN4IAHO02004 0,1307 0 0,8954 0 
FRMLR1IAHO02004 0,9896 0 0,0107 1 
Table 5.1. Wilcoxon rank sum test for PPG amplitude. 
  Report 
40   
Table 5.1. shows results from Wilcoxon test in which the results from delta left and right analysis are 
shown. We are going to consider only 19 of the 20 patients because one of the studied subjects did not 
have any stimulated apnea.  
Right analysis means that delta value for stimulated events (ON) is significantly higher than for non-
stimulated events (OFF), in other words, vasoconstriction is more significant in ON events. For this 
analysis, we have just one patient with a p-value lower than 0.05 that represents the 5,26% of our patient 
population. 
Left analysis means that delta value for non-stimulated events (OFF) is significantly higher than for 
stimulated events (ON), meaning vasoconstriction is more significant in OFF events. For PPG apnea 
analysis, we have 4 patients with a p-value lower than 0.05 which represents the 21,05% of our patient 
population. 
For the other patients, we did not obtain significative results (p<0,05). 
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5.1.2. Hypopnea 
 
Patients P-Value 
Hypopnea Right 
h2 Right P-Value 
Hypopnea Left 
h2 Left 
FRGNB4IAHO02009 0,0000 1 1,0000 0 
FRGNB4IAHO02010 0,0444 1 0,9559 0 
FRGNB4IAHO02012 0,5411 0 0,4625 0 
FRGNB4IAHO02013 0,0381 1 0,9623 0 
FRGNB4IAHO02014 0,7500 0 0,5000 0 
FRGNB4IAHO02015 0,1552 0 0,8488 0 
FRGNB4IAHO02016 0,6587 0 0,3464 0 
FRGNB4IAHO02017 0,3426 0 0,6841 0 
FRGNB4IAHO02018 0,7385 0 0,2631 0 
FRGNB4IAHO02019 0,0919 0 0,9106 0 
FRGNB4IAHO02020 0,9274 0 0,0736 0 
FRGNB4IAHO02022 0,3896 0 0,6116 0 
FRGNB4IAHO02023 0,5062 0 0,4979 0 
FRGNB4IAHO02024 0,0674 0 0,9340 0 
FRTRS5IAHO02007 0,0663 0 0,9344 0 
FRTRS5IAHO02010 0,5242 0 0,4879 0 
FRMLR1IAHO02001 0,6552 0 0,3520 0 
FRREN4IAHO02003 0,9722 0 0,0476 1 
FRREN4IAHO02004 0,3774 0 0,6251 0 
FRMLR1IAHO02004 0,8097 0 0,1934 0 
 
Table 5.2 Wilcoxon test results for PPG amplitude Hypopnea. 
 
Table 5.2. shows results from Wilcoxon test in which results from hypopnea delta left and right analysis 
are shown.  
Right analysis means that delta value for stimulated events (ON) is significantly higher than for non-
stimulated events (OFF), vasoconstriction is more significant in ON events. For this analysis, we have 3 
patients with a p-value lower than 0.05 which represents the 15% of our patient population. 
Left analysis means that delta value for non-stimulated events (OFF) is significantly higher than for 
stimulated events (ON), in other words, vasoconstriction is more significant in OFF events. For PPG 
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hypopnea analysis, we have 1 patient with a p-value lower than 0.05 which represents the 5% of our 
patient population.  
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5.2. PTT Results 
For PTT results the same presentation structure is followed. The analysis is divided in Apnea and 
Hypopnea, in each part we can find attached a table containing the Wilcoxon rank sum test, the tables 
containing the statistic parameters can be found in the annex. 
5.2.1. Apnea 
 
Patients P-Value Apnea 
Right 
h2 Right P-Value Apnea 
Left 
h2 Left 
FRGNB4IAHO02009 0,8622 0 0,1398 0 
FRGNB4IAHO02010 0,3225 0 0,6800 0 
FRGNB4IAHO02012 0,8779 0 0,1449 0 
FRGNB4IAHO02013 0,8885 0 0,1140 0 
FRGNB4IAHO02014 0,8191 0 0,2162 0 
FRGNB4IAHO02015 0,9167 0 0,0910 0 
FRGNB4IAHO02016 0,9881 0 0,0238 1 
FRGNB4IAHO02017 0,7376 0 0,2677 0 
FRGNB4IAHO02018 0,9631 0 0,0379 1 
FRGNB4IAHO02020 0,6786 0 0,4286 0 
FRGNB4IAHO02022 0,9543 0 0,0463 1 
FRGNB4IAHO02023 0,2566 0 0,7464 0 
FRGNB4IAHO02024 0,9864 0 0,0158 1 
FRTRS5IAHO02007 0,1692 0 0,8388 0 
FRTRS5IAHO02010 0,1351 0 0,8781 0 
FRMLR1IAHO02001 0,7334 0 0,2679 0 
FRREN4IAHO02003 0,2784 0 0,7227 0 
FRREN4IAHO02004 0,6797 0 0,3660 0 
FRMLR1IAHO02004 0,1471 0 0,8559 0 
 
Table 5.3 Wilcoxon test results for PTT Apnea. 
 
Table 5.3. shows results from PPG Wilcoxon test in which results from apnea delta left and right analysis 
are shown. We are going to consider only 19 of the 20 patients because one of the subjects did not have 
any stimulated apnea. 
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Right analysis means that delta value for stimulated events (ON) is significantly higher than for non-
stimulated events (OFF), which means that vasoconstriction is more significant in ON events. For this 
analysis, we have no patient with a p-value lower than 0.05 which represents the 0% of our patient 
population. 
Left analysis means that delta value for non-stimulated events (OFF) is significantly higher than for 
stimulated events (ON), meaning vasoconstriction is more significant in OFF events. For PTT apnea 
analysis, we have 4 patients with a p-value lower than 0.05 which represents the 21,05% of our patient 
population. 
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5.2.2. Hypopnea 
 
Patients P-Value 
Hypopnea 
Right 
h2 Right P-Value 
Hypopnea Left 
h2 Left 
FRGNB4IAHO02009 0,0008 1 0,9992 0 
FRGNB4IAHO02010 0,0012 1 0,9988 0 
FRGNB4IAHO02012 0,1439 0 0,8581 0 
FRGNB4IAHO02013 0,0040 1 0,9961 0 
FRGNB4IAHO02014 1,0000 0 0,2500 0 
FRGNB4IAHO02015 0,8006 0 0,2042 0 
FRGNB4IAHO02016 0,7581 0 0,2463 0 
FRGNB4IAHO02017 0,7581 0 0,2655 0 
FRGNB4IAHO02018 0,4021 0 0,5997 0 
FRGNB4IAHO02019 0,0168 1 0,9838 0 
FRGNB4IAHO02020 0,5150 0 0,4877 0 
FRGNB4IAHO02022 0,3837 0 0,6174 0 
FRGNB4IAHO02023 0,3490 0 0,6548 0 
FRGNB4IAHO02024 0,1403 0 0,8622 0 
FRTRS5IAHO02007 0,0249 1 0,9754 0 
FRTRS5IAHO02010 0,3810 0 0,6305 0 
FRMLR1IAHO02001 0,0818 0 0,9211 0 
FRREN4IAHO02003 0,2738 0 0,7897 0 
FRREN4IAHO02004 0,2884 0 0,7139 0 
FRMLR1IAHO02004 0,0601 0 0,9412 0 
Table 5.4. shows results from Wilcoxon test in which results from PTT hypopnea delta left and right 
analysis are shown.  
Right analysis means that delta value for stimulated events (ON) is significantly higher than for non-
stimulated events (OFF), which means that vasoconstriction is more significant in ON events. For this 
analysis, we have 5 patients with a p-value lower than 0.05 which represents the 25% of our patient 
population. 
Left analysis means that delta value for non-stimulated events (OFF) is significantly higher than for 
stimulated events (ON), which means vasoconstriction is more significant in OFF events. For PPG 
Table 5.4 Wilcoxon text results for PTT Hypopnea. 
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hypopnea analysis, we have 0 patients with a p-value lower than 0.05 which represents the 0% of our 
patient population.  
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6. Discussion 
Along this project apnea and hypopnea have been analysed to study the activation of parasympathetic 
system to influence blood vessels by means of kinaesthetic stimulation. After observing the obtained 
results, we can conclude that hypopneas have been treated in a too general way given that their 
morphologies can vary from one to another. In addition, oxygen saturation levels during respiratory 
events play a key role in autonomic nervous system activation as many other physiological aspects that 
were not taken into account. Finally, further analyses are needed and are being conducted to be able to 
reach a plausible conclusion for hypopneas. 
On the other hand, for apnea analysis we are able to observe important characteristics. To begin, we are 
going to discuss apnea results for PPG amplitude analysis. For the previous one, we had a population of 
19 subjects due to the fact that we had to delete one because it had no stimulated apnea and it could 
compromise our study. From the 19 remaining, we obtained a statistically significant decrease 
(p<0.05) in delta value for stimulated events respect to non-stimulated for 4 patients, who also had 
statistically significant decrease in their oxygen saturation analysis, which can be found in the annex. 
That means that their pulse wave amplitude increased after simulation as a result of blood vessels 
vasodilatation produced by a parasympathetic response to stimulation. These subjects had an average 
decrease of 43,57% of their delta mean value, meaning that their pulse amplitude was a 43,57% more 
similar on stimulated events. On the other hand, we obtained one subject which showed non-
stimulated PPG amplitude values with a lower delta value than stimulated ones, consequence of an 
increase of vasoconstriction due to sympathetic activation, which is the opposite effect we wanted to 
produce. This is a possibility that we had to have in mind, the possibility of producing the opposite 
effect than the desired one. That may be a consequence of bad patient population selection or due to 
other physiological activation aspects we did not take into account. In Figure 6.1 we can find a schema 
of the hypothetical physiological response to kinaesthetic stimulation. For the rest of the studied 
patient population we did not obtain significant results. 
After obtaining these results, we can affirm that the research is being conducted on the right direction, 
however, further analyses are needed to precise other physiological aspects that were not considered 
in this project. 
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Figure 6.1 Hypothetic physiologic response to kinaesthetic stimulation. 
For PTT apnea analysis, we counted on a 20-subject population. Out of which for 4 subjects we 
obtained statistically significant results (p<0.05). The previous showed a significant delta value 
which was lower for stimulated apnea than for non-stimulated ones, a mean of 65,48% lower for ON 
with respect from OFF events. Three out of these four subjects showed to be responders in oxygen 
saturation analysis. This effect is a consequence of stimulation which provoked a parasympathetic 
activation, decreasing heart rate and stroke volume, causing vasodilatation and finishing in an 
increase of pulse transit time which decreased delta value. In Figure 6.2 we can find a schema of the 
hypothetic physiological response to kinaesthetic stimulation. No statistically significant values were 
found for right sided analysis, so no opposite effect was produced in any subject. For the rest of 
subjects, we didn’t obtain significant results and further analyses should be carried on because, at the 
moment, it is not possible to determine the produced effect on them. 
Kinaesthetic 
stimulation
Parasympahtetic 
Activation
Heart Rate  
Stroke Volume  
Vasoconstriction  
PTT   ẟ  
 
Figure 6.2 Hypothetic physiological response to kinaesthetic stimulation. 
Sleep Apnea Syndrome (SAS) is a complex clinical problem which depends on several physiological 
aspects. Along this project, we have focused on the effect on parasympathetic activation regarding 
nothing but the response on PPG amplitude and PTT, but it should be studied taking into account 
many other aspects like oxygen saturation, personal illnesses, autonomic response or sleep stage, 
that’s why further research is being conducted.
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7. Conclusions 
Regarding the analysis of autonomic nervous system response analysis in subjects suffering from sleep 
apnea/ hypopnea syndrome we can firmly affirm that further research must be conducted. For apnea, in 
PPG amplitude and in PTT analysis we have obtained a 21,05% and 20% respectively of patient 
population who had a reduction effect on vasoconstriction. This percentage is too low to affirm that the 
proposed therapy developed a beneficial effect on vasoconstriction. On the other hand, it is not a low 
enough percentage to quit the research. Moreover, we just obtained one patient for PPG amplitude and 
none in PTT analysis which showed the contrary effect to the desired one. That means that the proposed 
therapy does not provoke cardiorespiratory system illnesses. 
For hypopnea, we obtained a 15% and a 20% of patient population for PPG amplitude an PTT analysis 
respectively who showed an increase of delta value, meaning that vasoconstriction was increased. 
Though, we concluded that for hypopnea the conducted analysis was too general given that these types 
of events can have a wide variety of morphologies with different physiological effects which should be 
deeply studied. 
In addition, for both apnea and hypopnea analysis, patients were eligible for the study if they had a 
history of severe obstructive sleep apnea within the past 6 months, with evidence of periodic breathing 
with apnea. Consequently, another cause for the lack of response may be due to inappropriate patient 
selection, for example patients presenting an autonomic dysfunction. Another cause may be that during 
data acquisition, stimulation properties (amplitude, burst duration, frequency) were the same for all 
patients and kept constant during the whole night, which should be improved to adapt it to patient 
characteristics to improve its performance. 
Regarding the experience of working in LTSI, there was a complete integration and adaptation in the 
team, as well as being familiar with the laboratory’s facilities and being used to its working environment. 
On the other hand, this internship has tough me how it is like to work in the research field, teaching me 
many things like how to look for inspiration in the literature when the analysis arrived to a dead end, 
how to ask for help whenever is needed and not feeling embarrassed about it, how to recognize different 
morphologies of QRS complexes even if they are upside down, how to detect respiratory cycles of all 
morphologies, and to improve my MATLAB skills among many others. But one of the most important 
things I have learned during these 5 months is how, through a computer, we can be able to observe 
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people’s health problems and, even though we can just see graphics or signals, never forget they come 
from a human being, always keeping in mind that our goal is to improve people’s quality of life. 
To end, this experience has also given me the opportunity to be in a foreign country and to improve my 
level of French and English language as well as the chance to meet people from all around the world, 
letting me discover their cultures and their opinions, broadening my horizons for starting new adventures 
in the future.  
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8. Economic Analysis 
In this section of the project all economic expenses are explained. The economic analysis will have the 
same scope as the project itself, which means, it will not have into account the cost of data acquisition 
and previous analysis carried on. More precisely, it will be divided into the following parts: Engineering 
costs and office IT costs. 
The engineering costs are estimated as 25 €/h as the average salary for a junior engineer. 
1.1. Engineering costs 
In this part of the economic analysis we are going to show the costs of engineering work for the different 
functions that needed to be done. 
Phase Hours €/h Phase cost (€) 
Literature Reading 31 25 775 
Codes development 413 25 10325 
Report writing 61 25 1525 
Meetings 6 25 150 
Total cost   12775 
 
Table 8.1 Engineering costs. 
1.2. Office IT costs 
As this project has been developed entirely in a computer soported base some licences are needed. The 
principal used programmes are MATLAB and pack Office 2017. 
Program Cost (€) 
MATLAB  500 
MATLAB Report Generator 200 
Signal Processing Toolbox 200 
Microsoft office professional 2016 253,90 
Total 1153,9 
Table 8.2 Office IT costs. 
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1.3. Total costs 
Finally, a table with all the expenses is presented. In this recap table, we can find the total of all 
previously presented tables and the expenses due to meetings with the research team and project 
coordinators. 
Concept Cost (€) 
Engineering Costs 12775 
Office IT 1153,9 
Total 13928,9 
Total (with IVA 21%) 16853,9 
 
Table 8.3 Total project costs. 
Finally, we can affirm that the total cost of hiring an intern to develop this project has been 16853,9€. 
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Annex  
PPG Amplitud statistic analysis for Apnea events 
 
Patients Mean 
Delta 
Apnea 
OFF 
Mean 
Delta 
Apnea 
ON 
Std 
Apnea 
OFF 
Std 
Apnea 
ON 
Median 
Apnea 
OFF 
Median 
Apnea 
ON 
Q3 
Apnea 
OFF 
Q3 Apnea 
ON 
Q1 
Apnea 
OFF 
Q1 
Apnea 
ON 
FRGNB4IAHO02009 63,8492 80,5103 35,2124 25,9662 60,6168 81,0223 87,7170 100,5690 40,3370 63,9980 
FRGNB4IAHO02010 4,0999 6,6497 21,4017 24,0415 2,1107 8,3010 17,5844 17,6910 -9,7856 -9,3050 
FRGNB4IAHO02012 23,6265 49,5143 31,0208 20,9310 24,1216 50,2324 43,0057 65,1158 1,8886 33,7332 
FRGNB4IAHO02013 40,6091 24,5033 35,4374 29,3273 34,7619 22,3387 61,6863 48,3376 19,7044 4,2883 
FRGNB4IAHO02014 17,0736 19,2272 10,7634 18,0208 13,5523 15,2449 25,2555 34,5973 9,7719 8,0748 
FRGNB4IAHO02015 57,6123 34,6423 28,3078 42,2207 51,9593 29,6230 64,0733 51,1341 39,1629 4,9855 
FRGNB4IAHO02016 23,0308 -3,5158 21,9277 34,7651 24,0753 -
17,0630 
41,1917 22,7218 15,5781 -26,3666 
FRGNB4IAHO02017 39,6105 46,1894 36,2903 48,9245 30,4938 41,2613 56,9798 81,2310 11,1864 2,9110 
FRGNB4IAHO02018 48,0747 31,5635 32,0257 25,1883 49,1320 29,5807 72,6884 57,9496 23,2134 12,2936 
FRGNB4IAHO02019 54,0688 NaN 36,9535 NaN 59,1676 NaN 74,2168 NaN 26,5417 NaN 
FRGNB4IAHO02020 54,5491 30,1405 22,1296 11,0041 54,5491 27,3542 70,1971 37,7235 38,9011 25,0120 
FRGNB4IAHO02022 29,9276 29,1275 17,9902 18,2297 25,1094 24,2956 38,1969 40,7654 18,6146 14,2819 
FRGNB4IAHO02023 34,5499 32,3815 24,7379 19,9259 30,9593 35,3852 49,1223 45,7181 16,7893 20,4852 
FRGNB4IAHO02024 49,1386 42,8116 25,3070 21,5841 47,0152 40,5031 59,9711 54,0869 28,5728 29,8012 
FRTRS5IAHO02007 0,0552 0,0522 0,0402 0,0373 0,0467 0,0349 0,0686 0,0750 0,0325 0,0271 
FRTRS5IAHO02010 0,0232 0,0455 0,0395 0,0402 0,0265 0,0488 0,0478 0,0801 0,0189 0,0193 
FRMLR1IAHO02001 0,7625 0,8984 0,9165 1,0811 0,6013 0,5620 1,1964 1,4311 0,2933 0,2354 
FRREN4IAHO02003 31,2444 26,2182 25,5979 24,9054 30,4965 19,2752 48,5337 42,2017 13,2606 11,5079 
FRREN4IAHO02004 10,0339 20,7389 12,6565 10,7343 7,8525 20,7389 19,4695 28,3292 1,1269 13,1486 
FRMLR1IAHO02004 0,0554 0,0460 0,0187 0,0222 0,0533 0,0389 0,0709 0,0530 0,0432 0,0338 
 
Table A.1  Statistic Analysis of PPG amplitude delta results for apnea 
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PPG Amplitud statistic analysis for Hypopnea events 
 
Patients Mean 
Delta 
Hypo 
OFF 
Mean 
Delta 
Hypo ON 
Std Hypo 
OFF 
Std Hypo 
ON 
Median 
Hypo 
OFF 
Median 
Hypo ON 
Q3 Hypo 
OFF 
Q3 Hypo 
ON 
Q1 Hypo 
OFF 
Q1 Hypo 
ON 
FRGNB4IAHO02009 33,2246 85,9816 37,7901 36,2884 36,6877 96,3220 61,2718 103,8530 7,4386 63,6629 
FRGNB4IAHO02010 21,5525 26,9783 20,5513 18,6614 20,3095 23,3697 34,7128 35,1496 8,3019 15,5839 
FRGNB4IAHO02012 21,0243 17,6183 27,3473 31,6012 16,9785 18,7861 42,1384 41,1915 -0,1191 -0,2109 
FRGNB4IAHO02013 16,3215 25,1171 32,1349 23,3243 13,4219 24,0510 35,5338 44,6394 0,0000 9,6924 
FRGNB4IAHO02014 18,0219 13,1536 0,0000 28,0544 18,0219 -0,6709 18,0219 33,9102 18,0219 -4,1470 
FRGNB4IAHO02015 44,7805 57,4718 38,7077 34,2579 35,1109 57,0698 64,9326 84,9707 23,6211 26,2670 
FRGNB4IAHO02016 37,5899 35,8521 32,2400 20,7324 39,4161 33,0472 62,4816 50,3567 18,2951 21,7371 
FRGNB4IAHO02017 22,4270 32,6036 35,2937 34,8770 22,9263 28,8091 40,7382 64,1404 1,1897 4,7133 
FRGNB4IAHO02018 39,8195 35,0571 35,8871 29,7854 35,7244 30,6922 66,0549 47,7806 15,3616 14,3634 
FRGNB4IAHO02019 42,9461 53,7599 33,5538 23,0677 42,4973 48,5513 68,8124 72,9893 16,4030 38,8494 
FRGNB4IAHO02020 28,1491 21,8358 23,8037 17,5676 27,2182 23,7205 42,7899 34,2109 13,3948 8,9431 
FRGNB4IAHO02022 23,3962 23,1031 20,4971 16,8086 17,9917 20,4810 37,7233 31,7352 8,4767 10,1223 
FRGNB4IAHO02023 32,8430 30,9473 28,9696 23,9750 27,5181 24,7787 49,4633 50,0529 11,6102 11,6126 
FRGNB4IAHO02024 38,1002 46,4409 20,8308 26,3042 37,7333 52,7888 50,9481 64,6775 23,1967 27,0037 
FRTRS5IAHO02007 0,0422 0,0474 0,0373 0,0328 0,0324 0,0372 0,0524 0,0556 0,0198 0,0265 
FRTRS5IAHO02010 0,0375 0,0487 0,0265 0,0517 0,0314 0,0395 0,0565 0,0502 0,0197 0,0170 
FRMLR1IAHO02001 0,9031 0,8242 0,6604 0,5690 0,8355 0,6967 1,2524 1,3231 0,4541 0,3332 
FRREN4IAHO02003 40,9476 20,5579 12,7257 17,6454 43,9103 15,0511 48,1189 37,9014 30,8998 9,5105 
FRREN4IAHO02004 15,7191 18,1673 20,2397 19,8374 17,9463 21,8147 29,7920 26,3447 2,7948 7,3023 
FRMLR1IAHO02004 0,0646 0,0578 0,0209 0,0186 0,0636 0,0638 0,0737 0,0686 0,0524 0,0507 
 
Table A.2 Statistic results for PPG amplitude for Hypopnea. 
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PTT statistic analysis for Apnea events 
 
Patients Mean 
Delta 
Apnea 
OFF 
Mean 
Delta 
Apnea 
ON 
Std 
Apnea 
OFF 
Std 
Apnea 
ON 
Median 
Apnea 
OFF 
Median 
Apnea 
ON 
Q3 
Apnea 
OFF 
Q3 
Apnea 
ON 
Q1 
Apnea 
OFF 
Q1 
Apnea 
ON 
FRGNB4IAHO02009 0,0445 0,0459 0,0578 0,0775 0,0373 0,0313 0,0532 0,0406 0,0170 0,0182 
FRGNB4IAHO02010 0,0004 0,0107 0,0488 0,0239 0,0074 0,0090 0,0241 0,0294 -0,0080 -0,0075 
FRGNB4IAHO02012 0,0339 0,0102 0,0376 0,0289 0,0305 0,0264 0,0388 0,0271 0,0162 -0,0108 
FRGNB4IAHO02013 0,0439 0,0190 0,0741 0,0172 0,0214 0,0144 0,0584 0,0272 0,0064 0,0075 
FRGNB4IAHO02014 0,0856 0,0155 0,1224 0,0045 0,0176 0,0154 0,1746 0,0175 0,0136 0,0126 
FRGNB4IAHO02015 0,0227 0,0171 0,0117 0,0160 0,0240 0,0126 0,0293 0,0156 0,0127 0,0089 
FRGNB4IAHO02016 0,0195 -0,0033 0,0090 0,0199 0,0186 0,0031 0,0202 0,0102 0,0126 -0,0184 
FRGNB4IAHO02017 0,0523 0,0457 0,0932 0,0949 0,0246 0,0144 0,0594 0,0594 0,0095 0,0046 
FRGNB4IAHO02018 0,0503 0,0379 0,0630 0,0636 0,0388 0,0296 0,0614 0,0397 0,0177 0,0115 
FRGNB4IAHO02019 0,0280 NaN 0,0206 NaN 0,0262 NaN 0,0421 NaN 0,0141 NaN 
FRGNB4IAHO02020 0,0516 0,0298 0,0454 0,0121 0,0516 0,0286 0,0837 0,0318 0,0195 0,0234 
FRGNB4IAHO02022 0,0543 0,0448 0,0733 0,0712 0,0324 0,0255 0,0519 0,0426 0,0205 0,0155 
FRGNB4IAHO02023 0,0347 0,0278 0,0563 0,0173 0,0236 0,0273 0,0333 0,0350 0,0153 0,0156 
FRGNB4IAHO02024 0,0345 0,0216 0,0214 0,0073 0,0313 0,0229 0,0366 0,0257 0,0255 0,0159 
FRTRS5IAHO02007 0,0703 0,1378 0,0772 0,1567 0,0480 0,0459 0,1088 0,3332 0,0190 0,0232 
FRTRS5IAHO02010 0,0324 0,0422 0,0492 0,0396 0,0297 0,0505 0,0438 0,0688 0,0105 0,0179 
FRMLR1IAHO02001 0,0219 0,0218 0,0547 0,0487 0,0134 0,0126 0,0267 0,0219 0,0070 0,0052 
FRREN4IAHO02003 0,0373 0,0256 0,0766 0,0267 0,0199 0,0229 0,0335 0,0438 0,0094 0,0069 
FRREN4IAHO02004 0,0118 0,0104 0,0053 0,0056 0,0126 0,0104 0,0164 0,0144 0,0094 0,0065 
FRMLR1IAHO02004 0,0269 0,0163 0,0713 0,0098 0,0120 0,0160 0,0203 0,0219 0,0069 0,0116 
 
Table A.3 Statistic analysis results for PTT analysis for Apnea. 
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PTT statistic analysis for Hypopnea events 
 
Patients Mean 
Delta 
Hypo 
OFF 
Mean 
Delta 
Hypo 
ON 
Std 
Hypo 
OFF 
Std 
Hypo 
ON 
Median 
Hypo 
OFF 
Median 
Hypo 
ON 
Q3 Hypo 
OFF 
Q3 Hypo 
ON 
Q1 Hypo 
OFF 
Q1 
Hypo 
ON 
FRGNB4IAHO02009 0,0190 0,0371 0,0142 0,0190 0,0164 0,0384 0,0238 0,0537 0,0109 0,0192 
FRGNB4IAHO02010 0,0270 0,0533 0,0291 0,0793 0,0242 0,0342 0,0374 0,0579 0,0097 0,0184 
FRGNB4IAHO02012 0,0182 0,0232 0,0137 0,0159 0,0165 0,0198 0,0254 0,0243 0,0096 0,0127 
FRGNB4IAHO02013 0,0126 0,0204 0,0188 0,0291 0,0113 0,0161 0,0191 0,0237 0,0000 0,0116 
FRGNB4IAHO02014 0,0381 0,0155 0,0000 0,0144 0,0381 0,0199 0,0381 0,0254 0,0381 0,0045 
FRGNB4IAHO02015 0,0242 0,0211 0,0215 0,0234 0,0193 0,0149 0,0305 0,0240 0,0108 0,0062 
FRGNB4IAHO02016 0,0310 0,0261 0,0232 0,0154 0,0267 0,0249 0,0479 0,0324 0,0180 0,0168 
FRGNB4IAHO02017 0,0458 0,0265 0,0654 0,0418 0,0410 0,0099 0,0642 0,0545 0,0065 0,0057 
FRGNB4IAHO02018 0,0406 0,0467 0,0604 0,0699 0,0289 0,0291 0,0451 0,0420 0,0170 0,0185 
FRGNB4IAHO02019 0,0234 0,0285 0,0198 0,0115 0,0186 0,0276 0,0323 0,0380 0,0103 0,0220 
FRGNB4IAHO02020 0,0263 0,0249 0,0188 0,0146 0,0224 0,0242 0,0369 0,0322 0,0131 0,0173 
FRGNB4IAHO02022 0,0418 0,0466 0,0675 0,0742 0,0238 0,0233 0,0349 0,0355 0,0124 0,0148 
FRGNB4IAHO02023 0,0316 0,0429 0,0336 0,0649 0,0253 0,0265 0,0360 0,0422 0,0127 0,0174 
FRGNB4IAHO02024 0,0213 0,0261 0,0158 0,0158 0,0187 0,0215 0,0287 0,0301 0,0120 0,0141 
FRTRS5IAHO02007 0,0623 0,0774 0,0925 0,0883 0,0269 0,0462 0,0491 0,0882 0,0144 0,0232 
FRTRS5IAHO02010 0,0240 0,0238 0,0225 0,0138 0,0176 0,0227 0,0285 0,0292 0,0106 0,0135 
FRMLR1IAHO02001 0,0200 0,0150 0,0440 0,0074 0,0113 0,0132 0,0162 0,0200 0,0081 0,0105 
FRREN4IAHO02003 -0,0691 0,0468 0,2186 0,0470 0,0251 0,0282 0,0365 0,0648 -0,1045 0,0191 
FRREN4IAHO02004 0,0188 0,0288 0,0299 0,0596 0,0165 0,0162 0,0201 0,0222 0,0111 0,0117 
FRMLR1IAHO02004 0,0228 0,0297 0,0449 0,0384 0,0145 0,0196 0,0207 0,0262 0,0089 0,0137 
 
Table A.4 Statistic results of PTT for Hypopnea. 
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Saturation Analysis delta method for Apnea 
 
  Num, 
ASOFF 
Num, 
ASON 
AON 
deltamean 
AON 
deltastd 
AOFF 
deltamean 
AOFF 
deltastd 
Adelta p 
value 
FRGNB4IAHO02009 89 26 139.848 157.056 484.585 102.147 1,0693 
FRGNB4IAHO02010 43 75 148.364 311.031 0,80062 324.728 0,9416 
FRGNB4IAHO02012 20 3 120.232 0,977865 615.966 347.469 0,0200 
FRGNB4IAHO02013 55 34 237.722 30.223 3.393 708.072 0,0052 
FRGNB4IAHO02014 33 33 597.825 383.992 51.729 383.696 0,9627 
FRGNB4IAHO02015 16 17 295.203 291.296 521.834 308.074 0,0122 
FRGNB4IAHO02016 7 3 122.468 0,686535 44.511 150.328 0,0083 
FRGNB4IAHO02017 54 27 270.415 209.405 541.348 127.707 0,0241 
FRGNB4IAHO02018 57 28 233.454 355.868 69.589 56.005 0,8488 
FRGNB4IAHO02019 12 0 NaN NaN 794.931 580.774 0,0000 
FRGNB4IAHO02020 2 6 180.766 595.814 0,496274 0,775577 0,9286 
FRGNB4IAHO02022 91 75 419.686 706.144 515.605 398.622 0,1949 
FRGNB4IAHO02023 125 52 232.693 415.622 19.813 263.477 0,7024 
FRGNB4IAHO02024 19 8 241.998 0,70752 535.133 421.041 0,0013 
FRTRS5IAHO02007 55 35 70.406 228.197 42.579 133.305 0,0899 
FRTRS5IAHO02010 52 32 191.323 246.845 229.237 13,8 0,9150 
FRMLR1IAHO02001 187 113 215.826 939.555 183.157 488.988 0,1239 
FRREN4IAHO02003 310 121 340.674 406.712 275.933 616.933 0,9635 
FRREN4IAHO02004 18 3 382.412 33.171 151.113 288.875 0,8306 
FRANG4IAHO02001 136 19 145.266 164.275 370.665 325.147 8,2467 
FRANG4IAHO02002 18 12 238.162 410.512 313.314 318.151 0,4747 
FRANG4IAHO02003 130 98 228.576 336.499 228.645 264.974 0,3121 
FRANG4IAHO02004 13 7 255.152 159.308 389.983 361.796 0,1917 
FRMLR1IAHO02004 89 32 0,859491 0,992649 298.776 119.073 0,3134 
 
Table A.5 Saturation analysis for Apnea with delta method. 
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Saturation Analysis delta method for Hypopnea 
 
  Reference 
ON Mean 
Reference 
ON Std 
Reference 
OFF Mean 
Reference 
OFF Std 
p value Overlapped 
Windows 
Same Delta 
From 
Overlapped 
Windows 
FRGNB4IAHO02009 962.981 0,7394 957.096 0,8682 0,0033 15 0 
FRGNB4IAHO02010 941.613 13.761 938.037 142.364 0,0517 38 0 
FRGNB4IAHO02012 918.528 136.831 914.678 168.738 0,2500 5 0 
FRGNB4IAHO02013 95.255 163.133 949.021 155.472 0,0406 44 0 
FRGNB4IAHO02014 955.505 173.236 965.667 0 0,7500 1 0 
FRGNB4IAHO02015 93.287 202.217 933.491 168.523 0,6450 0 0 
FRGNB4IAHO02016 96.655 120.296 966.377 126.078 0,4647 7 0 
FRGNB4IAHO02017 935.177 0,4607 939.806 237.688 0,8893 0 0 
FRGNB4IAHO02018 963.363 194.709 962.488 173.169 0,1474 21 0 
FRGNB4IAHO02019 951.345 13.685 933.665 29.704 0,0034 3 0 
FRGNB4IAHO02020 956.414 162.822 956.807 130.978 0,5519 41 0 
FRGNB4IAHO02022 951.431 231.611 956.623 229.476 0,9817 30 0 
FRGNB4IAHO02023 934.258 176.325 940.091 135.772 0,9255 8 0 
FRGNB4IAHO02024 977.767 0,8059 971.084 153.885 0,0073 20 0 
FRTRS5IAHO02007 975.597 115.888 972.872 158.404 0,1577 14 0 
FRTRS5IAHO02010 947.231 140.798 939.582 110.862 0,0171 16 0 
FRMLR1IAHO02001 836.332 571.698 849.288 465.422 0,8088 4 0 
FRREN4IAHO02003 856.277 691.789 914.332 173.669 0,9995 4 0 
FRREN4IAHO02004 906.045 226.824 907.828 170.412 0,5457 8 0 
FRANG4IAHO02001 897.255 243.977 925.028 188.135 0,9965 9 0 
FRANG4IAHO02002 927.077 165.163 92.352 159.224 0,0826 15 0 
FRANG4IAHO02003 895.053 210.245 897.652 210.351 0,7081 10 0 
FRANG4IAHO02004 920.654 209.318 914.447 152.815 0,2482 1 0 
FRMLR1IAHO02004 957.038 109.409 951.074 150.609 0,0366 8 0 
Table A.6 .Saturation Analysis of hypopnea for delta method. 
